Andreas G Weichert

Pharmaceutical R&D Expert
Pharmaceuticals

Experience

Principal & Owner
Dr. Weichert - Life Sciences Consulting
Pharmaceuticals
July 2007 - Present

Founded independent project management and business development firm specializing in value creation tied to cross-industrial innovation experience, market expertise and expert partner network: - Preclinical strategic and technical R&D consulting - ID of technology/service provider, management of feasibility studies and IP generation - Assessment of clients technology and IP assets for partnering/sales process - New business development in Europe for international Pharma CROs


Associate Director & Research Advisor
Eli Lilly
Public Company; Pharmaceuticals
May 2003 - June 2007

- Accountable for local discovery chemistry department and portfolio deliverables - Managed department staff and held full budget responsibility - Implemented new lead generation paradigm which led to improved productivity - Contributed to global management team and local site lead team decisions - Influenced scientific R&D review and governance teams in all major therapeutic areas - Involved in global resource allocation and people management measures - Represented global function in technical due-diligence activities


Principal Research Scientist
Lilly Research Laboratories
Pharmaceuticals
January 2001 - April 2003

Devised MedChem strategies for diabetes projects, led research teams based on data generated by several scientific disciplines: - Contributed to clinical candidate selections - Invented novel compound class and successfully secured intellectual property protection


Research Scientist
Hoechst AG, Hoechst Marion Roussel, Aventis
Pharmaceuticals
December 1991 - December 2000

Provided scientific project support in cardiovascular, metabolic and inflammatory disease areas, led research lab and supervised associates: - Conceived and produced novel compounds, among them Cariporide mesylate (INN), which was tested in phase III clinical trials - Introduced modern chemical synthesis techniques


Postdoctoral Fellow - Bioorganic Chemistry
Stanford University
Educational Institution; Higher Education
March 1990 - September 1991

Worked in Prof. Paul Wender's research group on antitumor antibiotics (dynemicin analogs)


Education

Universitt Hannover / University of Hanover
Organic Chemistry
1987 - 1989

Universitt Hannover / University of Hanover
Chemistry
1981 - 1987

Patents (34)

Substituted arylcyclopropylacetamides as glucokinase activators (2 worldwide citation)
Andreas Gerhard Weichert, David Gene Barrett, Stefan Heuser, Rainer Riedl, Mark Joseph Tebbe, Andrea Zaliani
August 18, 2009: 07576108

Substituted phenylalkenoylguanidines, process for their preparation, and their use in medicaments and in diagnostics
Andreas Weichert, Alfons Enhsen, Eugene Falk, Hans Willi Jansen, Werner Kramer, Jan Robert Schwark, Hans Jochen Lang
December 26, 2000: 06166002

4-fluoroalkyl-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them (4 worldwide citation)
Andreas Weichert, Joachim Brendel, Heinz Werner Kleemann, Hans Jochen Lang, Jan Robert Schwark, Wolfgang Scholz, Udo Albus
December 5, 2000: 06156800

Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them
Udo Albus, Joachim Brendel, Heinz Werner Kleemann, Hans Jochen Lang, Wolfgang Scholz, Jan Robert Schwark, Andreas Weichert
November 28, 2000: 06153651

Substituted bicyclic heteroaroylguanidines, a process for their preparation, their use as a medicament or a diagnostic agent, and a medicament containing them
Jan Robert Schwark, Heinz Werner Kleemann, Hans Jochen Lang, Andreas Weichert, Wolfgang Scholz, Udo Albus
July 25, 2000: 06093729

Substituted 2-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them (5 worldwide citation)
Joachim Brendel, Heinz Werner Kleemann, Heinrich Christian Englert, Hans Jochen Lang, Jan Robert Schwark, Andreas Weichert, Bansi Lal
July 11, 2000: 06087304

Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them
Andreas Weichert, Joachim Brendel, Heinz Werner Kleemann, Hans Jochen Lang, Jan Robert Schwark, Udo Albus, Wolfgang Scholz
June 13, 2000: 06075054

Basically-substituted benzoylguanidines, a process for preparing them, their use as a medicament or diagnostic agent, and a medicament containing them (5 worldwide citation)
Heinz Werner Kleemann, Hans Jochen Lang, Jan Robert Schwark, Andreas Weichert, Wolfgang Scholz, Udo Albus
May 2, 2000: 06057322


Substituted benzyloxy-carbonylguanidines, a process for their preparation, their use as a medicament or diagnostic, and a medicament containing them
Heinz Werner Kleemann, Joachim Brendel, Jan Robert Schwark, Andreas Weichert, Hans Jochen Lang, Udo Albus, Wolfgang Scholz
February 8, 2000: 06022899

Connections (157)
Sheraz Gul
VP & Head of Biology at European ScreeningPort GmbH

John J Masters
Director of Business Development at BioDuro, a PPD Company

Alan Palkowitz
Vice President, Discovery Chemistry at Eli Lilly and Company